
|Podcasts|August 6, 2020
Episode 62: The Future of Pharma’s Supply Chain
Author(s)Elaine Quilici
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.
Advertisement
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
2
Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton
3
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
4
Amazon Pharmacy Launches GLP-1 Delivery Service
5
